Takeda Oncology

Decades of leadership in Oncology with a diverse and robust pipeline

Oncology Pipeline

Discovering and developing innovative therapies to deliver potentially transformative treatments

Our Profile

We aspire to cure cancer with inspiration from patients and innovation from everywhere

Patient Advocacy

We are committed to helping people with cancer navigate every part of their journey

Partnership Strategy

We believe the best way to achieve our aspiration to cure cancer is by working together

Our People and Culture

We empower our people to realize their potential through life-changing work

Our Viewpoints

sample-gallery-thumb-image
Lessons From Evolution: From Innate Immunity to Novel Cancer Immunotherapies

In recent years, we’ve seen remarkable progress in combatting devastating cancers, with the rise of immunotherapies across a breadth of therapeutic modalities, from antibody-based immunomodulators to cell-based therapies to other emerging technologies. And yet, while there are more than 30 approved immunotherapies on the market today, only about 15-20% of patients respond to available treatments, demonstrating a necessity for more effective and tolerable options.